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ABSTRACT 23 
Our previous study demonstrated that the abundance of extracellular matrix proteins was suppressed by 24 
store-operated Ca
2+
 entry in mesangial cells (MCs). The present study was conducted to investigate the 25 
underlying mechanism focused on the transforming growth factor beta 1 (TGFβ1) - Smad3 pathway, a 26 
critical pathway for ECM expansion in diabetic kidneys. We hypothesized that SOCE suppressed ECM 27 
protein expression by inhibiting this pathway in MCs. In cultured human MCs, we observed that TGFβ1 28 
(5 ng/ml for 15 hours) significantly increased Smad3 phosphorylation as evaluated by immunoblot. 29 
However, this response was markedly inhibited by thapsigargin (1 µM), a classical activator of store-30 
operated Ca
2+
 channel. Consistently, both immunocytochemistry and immunoblot showed that TGFβ1 31 
significantly increased nuclear translocation of Smad3 which was prevented by pre-treatment with 32 
thapsigargin. Importantly, the thapsigargin effect was reversed by Lanthanum (La
3+
) (5 µM) and GSK-33 
7975A (10 µM), both of which are selective blockers of store-operated Ca
2+
 channel. Furthermore, 34 
knockdown of Orai1, the pore-forming subunit of store-operated Ca
2+
 channel, significantly augmented 35 
TGFβ1-induced Smad3 phosphorylation. Overexpression of Orai1 augmented the inhibitory effect of 36 
thapsigargin on TGFβ1-induced phosphorylation of Smad3. In agreement with the data from cultured 37 
MCs, in vivo knockdown of Orai1 specific to MCs using a targeted nanoparticle siRNA delivery system 38 
resulted in marked increase in abundance of phosphorylated Smad3 and in nuclear translocation of 39 
Smad3 in glomerulus of mice. Taken together, our results indicate that store-operated Ca
2+
 entry in MCs 40 
negatively regulates the TGFβ1-Smad3 signaling pathway.  41 
  42 
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INTRODUCTION 67 
Progressive accumulation of extracellular matrix (ECM) proteins in the glomerulus is one of the 68 
consistent pathological changes initiated at an early stage in kidney diseases such as diabetic 69 
nephropathy (DN) (24; 47). The magnitude of matrix accumulation in both the glomeruli and the 70 
interstitium is intensely and independently associated with the degree of renal insufficiency and 71 
proteinuria in patients with the renal dysfunction (51). Over extended period of time, the ECM 72 
accumulation and its dysregulated remodeling contributes to irreversible fibrotic changes that lead to 73 
chronic kidney disease and ultimately kidney failure in the form of end stage renal disease (13; 45). 74 
Glomerular mesangial cells (MCs) which are one of the major sources of ECM proteins are also an 75 
important target of metabolic abnormalities in diabetic environment (1; 18). Since ECM expansion in 76 
the mesangium is one early feature of DN (47), it is important to study the mechanisms that regulate 77 
ECM dynamics in MCs.  78 
Store operated Ca
2+
 entry (SOCE), which regulates many physiological and pathological 79 
functions in variety of cells, is an important Ca
2+
 signaling pathway in MCs (29; 35; 43). In our previous 80 
study, we demonstrated a negative effect of SOCE on the content of ECM proteins like fibronectin and 81 
collagen-IV (Col IV) in MCs (61), suggesting an anti-fibrotic effect of SOCE in MCs. However, the 82 
mechanism underlying the inhibitory effect of SOCE on ECM protein expression is not known. 83 
Transforming growth factor beta1 (TGFβ1), a multifunctional cytokine, plays a critical role in ECM 84 
protein dynamics (17; 19; 37; 40). It exerts its potent fibrotic effect intracellularly via receptor operated 85 
Smad (R-Smad) proteins, particularly Smad3 (21; 26; 44; 46; 55; 56).  Activation of Smad3 by TGFβ1 86 
through phosphorylation and subsequent translocation into the nucleus, regulates the transcription of 87 
target genes including those encoding or regulating ECM proteins (4; 12; 25; 26). In this study, we 88 
investigated if SOCE-induced suppression of fibronectin and Col IV was mediated by inhibition of the 89 
TGFβ1-Smad3 pathway.  90 
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MATERIAL AND METHODS 92 
Mesangial Cell culture Human MCs   were purchased from Lonza (Catalogue no:CC2559, 93 
Walkersville, MD). MCs in a 75-cm
2
 flask were cultured in 5.6 mM glucose DMEM (GIBCO, Carlsbad, 94 
CA) supplemented with 25 mM HEPES, 4 mM glutamine, 1.0 mM sodium pyruvate, 0.1 mM 95 
nonessential amino acids, 100 U/ml penicillin, 100 μg/ml streptomycin, and 20% fetal bovine serum 96 
(FBS). When MCs reached 90% confluence, the cells were split into 60 mm or 35 mm culture plates for 97 
various treatments as specified in figure legends. The cell growth was arrested with 0.5% FBS medium 98 
during treatments. The culture media was replaced every 2 days with fresh media. Activators or 99 
inhibitors of SOCE were added 20 min before TGFβ1 treatment. Cells used were with sub-passages not 100 
more than nine generations. 101 
Transient transfection of human MCs Small interfering (si) RNA against human Orai1 or 102 
scrambled control siRNA (both 50 nM) were transfected into human MCs using Dharmafect 2 103 
transfection reagent (Thermo Scientific, Rockford, IL) in serum free DMEM media following the 104 
protocol provided by the manufacturer. Media was changed to 20% FBS DMEM media after 6 h.  Cells 105 
were harvested for Western blot 72 h after transfection. Expression plasmid of Orai1 (FLAG-Orai1) and 106 
empty vector (yellow fluorescent protein, YFP) were transfected into MCs at 0.5 µg/ml using 107 
Lipofectamine and Plus reagent (Invitrogen-BRL, Carlsbad, CA) following the protocols provided by 108 
the manufacturer. Cells were collected 48 h after transfection for immunoblot analysis.  109 
Preparation of nuclear extracts Preparation of nuclear extracts from human MCs was 110 
performed using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Catalogue No: 78833, Thermo 111 
Scientific, Rockford, IL) following the manufacturer’s protocol. The extracts were stored at -80⁰C until 112 
use. 113 
Immunoblot Analysis Immunoblot analysis was performed as described in our previous 114 
publications (7). Briefly, the whole-cell lysates were fractionated by 10% SDS-PAGE, transferred to 115 
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PVDF membranes, and probed with primary antibodies to Smad3, phospho-Smad3 (p-Smad3), Orai1, 116 
TGFβ1, FLAG, TATA binding protein (TBP) and tubulin. Bound antibodies were visualized with Super 117 
Signal West Femto or Pico Luminol/ Enhancer Solution (Catalogue No: 34095 and 34087, Thermo 118 
Scientific, Rockford, IL). The specific protein bands were visualized and captured using the AlphaEase 119 
FC Imaging System (Alpha Innotech, San Leandro, CA). The integrated density value (IDV) of each 120 
band was measured by drawing a rectangle outlining the band using AlphaEase FC software with 121 
autobackground subtraction. In term of p-Smad3 (Figs. 2-5), we only measured the IDV of the major 122 
band at a molecular size of ~60 kDa, which represents p-Smad3 protein. The expression of TGFβ1 123 
protein was quantified by normalization of the IDV of the protein band to that of tubulin band on the 124 
same blot.  The expression of p-Smad3 protein was quantified by normalization of the IDV of p-Smad3 125 
bands to that of Smad3 band on the same blot except Fig. 5 in which the expression of nuclear p-Smad3 126 
protein was normalized to TBP. 127 
ELISA Abundance of TGFβ1 in supernatant media was determined by a solid-phase sandwich 128 
enzyme-linked immunosorbent assay (ELISA) using a DuoSet ELISA Development kit for TGFβ1 129 
(Catalogue No: DY240-05, R&D System, Minneapolis, MN, USA). Briefly, MCs were plated in 24 well 130 
plates as 1.8 × 10
4 
cells per well. When cells were confluent, they were serum deprived till the end of 131 
experiment. SOCE was activated by treating these cells with 1µM thapsigargin (TG) for 8 h before 132 
collection of their supernatant. The collected supernatant media was centrifuged at 1500 rpm for 10 min 133 
at 4
0
C and stored at -80
0C until use. Latent TGFβ1 in the cell supernatants was activated with 134 
acidification of samples by 1.0 N HCl and subsequent neutralization with 1.2 N NaOH/0.5 M HEPES 135 
and assayed immediately using the protocol provided by the manufacturer. The optical density was 136 
determined using the microplate reader set to 450 nm. TGFβ1 concentration in the media was 137 
determined from the standard curve obtained using the Sigma plot software version 11. 138 
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Immunofluorescence Cytochemistry Human MCs were plated on 22 × 22 × 1 mm glass 139 
coverslips in 35-mm culture dishes. Cells were treated with TGFβ1 (5 ng/ml) for 15 h, with or without 140 
TG (1µM) and GSK-7975A (10 µM). GSK-7975A was added 20 min before addition of TG which was 141 
applied 20 min prior to TGFβ1 treatment. After 15 h, cells were washed with PBS and fixed with 4% 142 
paraformaldehyde for 15 min at room temperature. After another wash with PBS, the cells were then 143 
incubated with ice-cold acetone at -20°C for 10 min. After 30 min of incubation with blocking buffer, 144 
the cells were incubated with mouse anti-Smad3 primary antibody at 1:100 in PBS plus 10% donkey 145 
serum and 0.2% Triton X-100 at 4 °C overnight. After three washes with PBS, the cells were then 146 
incubated with donkey anti-mouse secondary antibody conjugated with Alexa Fluor 568 (Catalogue No: 147 
A10037, Invitrogen) at a concentration of 1:500 for 1 h at 4
0
C in dark.  4’, 6-diamidino-2-phenylindole 148 
(DAPI, Catalogue No: H-1200, Invitrogen) was used for staining nuclei. Fluorescent staining was 149 
examined using an Olympus microscope (BX41) equipped for epifluorescence and an Olympus DP70 150 
digital camera with DP manager software (version 2.2.1). Images were converted to 16-bit format and 151 
uniformly adjusted for brightness and contrast using ImageJ (version 1.47; NIH). 152 
Fluorescence Measurement of [Ca
2+
]i  Measurements of [Ca
2+
]i in human MCs using fura-2 153 
were performed using dual excitation wavelength fluorescence microscopy. MCs grown on a coverslip 154 
(22  22 mm) were loaded with 2 μM acetoxymethyl ester of fura-2 (fura-2/AM) plus  0.018 g/dl 155 
Pluronic F-127 (Invitrogen, Grand Island, NY)  for 50 min at room temperature followed by additional 156 
20 min incubation in fura-2 free physiological saline solution. The coverslip was then placed in a 157 
perfusion chamber (Warner, Model RC-2OH) mounted on the stage of a Nikon Diaphot inverted 158 
microscope. Fura-2 fluorescence was monitored at 340 and 380 nm excitation wavelengths and at 510 159 
nm emission wavelength using NIS Elements AR
TM
 software (Nikon Instruments Inc., Melville, NY) at 160 
room temperature. [Ca
2+
]i was calculated using the software following the manufacturer’s instructions. 161 
Calibrations were performed at the end of each experiment, and conditions of high [Ca
2+
]i were achieved 162 
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by addition of 5 M ionomycin, whereas conditions of low [Ca2+]i were obtained by addition of 5 mM 163 
EGTA. 164 
Animals All procedures were approved by the University of North Texas Health Science Center 165 
(UNTHSC) Institutional Animal Care and Use Committee. Ten male C57BL/6 mice were purchased 166 
from Charles River Laboratories (Wilmington, MA). All mice used in this study were between 2 and 4 167 
months of age. The animals were maintained at the animal facility of UNTHSC under local and National 168 
Institutes of Health guidelines. 169 
  In Vivo Delivery of nanoparticles (NPs) into the Kidney of Mice The targeted NP-delivery 170 
system was used to deliver siRNA against Orai1 to the kidney of mice as previously described (61; 65). 171 
The compositions and formulation of the NP/siRNA complex were described previously (65).  Mice 172 
were randomly divided into control and Orai1–knocked down groups (five mice in each group). Tail 173 
vein injection of NPs containing Cy3- tagged siRNA against mouse Orai1 (NP-Cy3- siOrai1) were given 174 
at a dose of 10 mg/kg siRNA in a volume of 100 µl to the mice in the Orai1–knocked down group. The 175 
mice in the control group were only given unconjugated NPs through the same route at the same 176 
injection volume. These intravenous injections were given on day 1 and 3 of the experiment and the 177 
mice were euthanized on day 5. Mice were euthanized via intraperitoneal injection of pentobarbital (100 178 
mg/kg body weight). Kidneys were perfused with PBS to wash out the blood and the left kidney was 179 
removed and fixed in 4% paraformaldehyde. Paraformaldehyde-fixed kidney was embedded in molten 180 
paraffin and then, was sectioned at 4 µm in thickness (Cryostat 2800 Frigocut-E; Leica Instruments) for 181 
immunohistochemical examination. 182 
Immunofluorescent staining Anti α8 integrin rabbit polyclonal antibody at 1:50 and Alexa 183 
Fluor 488 Donkey anti-rabbit IgG (Catalogue no: A21206, Invitrogen, Eugene, OR) at 1:200 were used 184 
to label mouse glomerular MCs. Anti-synaptopodin goat polyclonal antibody at 1:50 and Alexa Fluor 185 
488 donkey anti goat IgG (Catalogue no: A11055, Life Technologies, Eugene, OR) at 1:200 was used to 186 
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label the podocytes. Sections were visualized using an Olympus microscope (BX41) equipped for 187 
epifluorescence and an Olympus DP70 digital camera with DP manager software (version 2.2.1). Images 188 
were converted to 16-bit format and uniformly adjusted for brightness and contrast using Image J 189 
(version 1.50b, NIH).  190 
Immunohistochemistry After rehydration, antigen retrieval was achieved by heating the 191 
sections in 10 mM citrate buffer in a microwave for 10 min. The sections were blocked by 5% goat 192 
serum for 30 min at room temperature and then were incubated with anti p-Smad3 rabbit antibody at 193 
1:100 at 4
0
C overnight. The sections were incubated with anti-rabbit poly HRP IHC reagent (Catalogue 194 
no: IHC-2291, General Bioscience Corporation) at room temperature for 1 h, followed by incubation 195 
with peroxidase substrate solution for about 2-3 min, dipping the slides in hematoxylin solution for 90 196 
seconds, dehydration in incubator at 60
0
C for 30 min and cover slips with mounting media containing 197 
DAPI.  Sections were examined using an Olympus microscope (BX41) and an Olympus DP70 digital 198 
camera with DP manager software (version 2.2.1). Images were uniformly adjusted for brightness and 199 
contrast and converted to 8-bit format for measuring intensity of staining using Image J (version 1.50b, 200 
NIH). 201 
 Materials Primary antibodies against p-Smad3 (ab51451) and TBP (ab818) were purchased 202 
from Abcam (Cambridge, MA). Primary antibodies against Smad3 (sc101154), integrin α8:H-180 (sc-203 
25713), synaptopodin (P-19) (sc-21537) and α-tubulin (sc-5286) were purchased from Santa Cruz 204 
Biotechnologies (Dallas, TX). Primary antibodies against Orai1 (O8264) and FLAG fusion proteins 205 
(A8592) were purchased from Sigma-Aldrich, (Israel). Secondary antibodies for western blot, goat anti 206 
mouse Ig HRP (sc2005) and goat anti rabbit Ig HRP (sc2003) were purchased from Santa Cruz 207 
Biotechnologies. Small interfering (si) RNA against human Orai1and Cy3–labeled siRNA against 208 
mouse Orai1 were purchased from Integrated DNA Technologies, Inc. (Chicago, IL) (Table 1). 209 
Scramble control siRNA (ON-TARGETplus Non-targeting control siRNA#1) (D-001810-01-20) was 210 
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purchased from Dharmacon, GE. mCherry- Red-Orai1/p3X FLAG-CMV 7.1 expression plasmid was 211 
obtained from Dr. Yuan at UNTHSC.  212 
TG (T9033) and Hematoxylin (GHS3) were purchased from Sigma-Aldrich. Human 213 
recombinant TGFβ1 (240-B-002) was purchased from R&D systems. GSK-7975A was kindly donated 214 
by GlaxoSmithKline (Brentford, UK). Peroxidase substrate solution (DAB Peroxidase substrate kit SK-215 
4100) was purchased from Vector Laboratories (Burlingame, CA). 216 
Statistical Analyses Data were reported as mean ± SEM. The one-way repeated measures of 217 
ANOVA plus Student-Newman–Keuls post hoc analysis and unpaired t-test were used to analyze the 218 
differences among multiple groups and between two groups, respectively, unless indicated in individual 219 
figures. P<0.05 was considered statistically significant. Statistical analysis was performed using 220 
SigmaStat (Jandel Scientific, San Rafael, CA). 221 
  222 
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RESULTS 223 
SOCE activation did not alter amount of secreted TGFβ1 by human MCs.  224 
MCs are known to synthesize and secrete TGFβ1 (23; 58; 62). To study if Ca2+ entry via store-225 
operated Ca
2+
 channel, i.e. SOCE affected secretion of TGFβ1 by MCs, we activated store-operated Ca2+ 226 
channel by treating the cells with 1 µM TG for 8 and 15 h. ELISA assay showed that TG treatment for 227 
both time periods did not significantly change the concentration of TGFβ1 in the cell culture media (Fig. 228 
1). These results indicate that SOCE did not affect the amount of secreted TGFβ1 protein by MCs. 229 
SOCE inhibited TGFβ1 induced phosphorylation of Smad3. 230 
A variety of stimuli such as Angiotensin II, high glucose, advanced glycosylation end products, 231 
and reactive oxygen species activate TGFβ1 to regulate expression of matrix proteins by MCs (16; 22; 232 
53). One of the major intracellular downstream pathways mediating this effect has been demonstrated to 233 
be via the activation of Smad proteins, particularly Smad3 (14; 25; 27; 30; 31; 48). In agreement with 234 
those studies, we also  found that administration of TGFβ1 (5 ng/ml), but not its vehicle control (HCl) 235 
for 15 h induced a robust increase in the content of phospho-Smad3, the active form of Smad3, in human 236 
MCs (Fig. 2 A&B). Activation of store-operated Ca
2+
 channel by TG significantly attenuated the TGFβ1 237 
response. However, the content of total Smad3 did not have significant change. These results indicate 238 
that SOCE   inhibits activation of the TGFβ1-Smad3 pathway in MCs.       239 
Knockdown of Orai1 increased while overexpression of Orai1 decreased the TGFβ1-induced 240 
phosphorylation of Smad3.  241 
Further, we speculated that knocking down the pore forming unit of store-operated Ca
2+
 channel 242 
may have an opposite effect to that of activation of the channel. Indeed, TGFβ1-induced 243 
phosphorylation of Smad3 was further and significantly increased in human MCs transfected with Orai1 244 
siRNA as compared to untransfected cells and scramble siRNA-transfected cells. (Fig3 A&B). 245 
Simultaneous activation of store-operated channel using 1 µM TG attenuated the enhanced response. 246 
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Western blot showed that Orai1 protein abundance was significantly reduced by its siRNA treatment 247 
(Fig. 3A).  248 
To support these findings, we next overexpressed Orai1 protein in human MCs with FLAG-249 
Orai1. The expressed Orai1 band was detected at approximately 80 kDa (Fig. 4C). As shown in Fig. 4 250 
A&B, activation of SOCE by TG significantly decreased TGFβ1-induced phosphorylation of Smad3. 251 
This inhibition was further augmented by overexpressing Orai1. To verify if the expressed Orai1 was 252 
functional, we carried out Ca
2+
 imaging experiments to measure SOCE in human MCs with and without 253 
expressing Orai1 using a classical Ca
2+
 re-addition protocol (35). As shown in Fig. 4D, the TG-254 
stimulated SOCE response was significantly greater in human MCs transfected with FLAG-Orai1 255 
compared with the response in MCs without transfection or transfected with YFP control plasmid.   256 
SOCE decreased TGFβ1-mediated nuclear translocation of Smad3 in human MCs. 257 
Activation of Smad3 by TGFβ1 involves its phosphorylation and subsequent translocation to the 258 
nucleus where it regulates the transcription of target genes. Published study demonstrated that TGFβ1 at 259 
5 ng/ml stimulated nuclear translocation of Smads 15 h after treatment (57). We thus examined 260 
abundance of phosphorylated Smad3 in the nuclear extracts of human MCs treated with TGFβ1 at 5 261 
ng/ml for 15 h with or without activation of store-operated Ca
2+
 channel. As shown in Fig. 5 A&B, 262 
translocation of phosphorylated Smad3 to the nucleus was significantly increased by TGFβ1 treatment. 263 
TG significantly reduced this translocation while simultaneous treatment with La
3+
 at 5 µM, which we 264 
have previously shown to block store-operated Ca
2+
 channel in human MCs (35), reversed the TG effect. 265 
Consistently, immunofluorescence study showed that Smad3 was localized in the cytosol in a large 266 
population of human MCs without stimulation. However, in the cells treated with TGFβ1, Smad3 was 267 
predominantly localized in the nucleus. TG inhibited this translocation, indicated by presence of Smad3 268 
in the cytosol. The inhibitory effect of TG was abolished when the cells were simultaneously treated 269 
with a selective inhibitor of store-operated Ca
2+
 channel, GSK-7975A (10 µM) (Fig. 5 C&D). 270 
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In Vivo knockdown of Orai1 in MCs increased phosphorylation and nuclear translocation of 271 
Smad3 in mice.   272 
We next verified our in vitro findings in mice with knockdown of Orai1 in MCs using the 273 
established targeted NP-siRNA delivery system (64; 65). In our previous study, we injected the NP 274 
carriers containing Cy3-tagged siRNA against mouse Orai1 (NP-Cy3-siOrai1) into mice via the tail vein 275 
twice one week (61).
 
We showed that the abundance of Orai1 protein was significantly reduced in the 276 
renal cortex from the mice receiving NP-Cy3-siOrai1 (61). During the one week of treatment period, 277 
there was no change in body weight, food intake and 24 h urine output in the mice treated with NP-Cy3-278 
siOrai1 (data not shown). Using the kidney sample from that study, we conducted a series of 279 
immunofluorescence examinations. Consistent with our previous studies (61; 65), these NP-siRNA 280 
complexes were predominantly distributed in glomeruli with limited distribution in surrounding tubules 281 
(Fig. 6A).  Next, we counterstained kidney sections from mice that received NP-Cy3-siOrai1 with a MC 282 
marker integrin α8 and a podocyte marker synaptopodin. As shown in Fig. 6B, the NP-Cy3-siOrai1 283 
complexes highly co-localized with the integrin α-8, but were not colocalized with synaptopodin, 284 
suggesting that the NP-siRNA complexes were selectively delivered into MCs. 285 
We next conducted immunohistochemical examination of the kidney sections from the mice with 286 
and without knockdown of Orai1. Smad3 protein was probed with the primary antibody of anti-287 
phospho-Smad3, shown as brown color. The cell nucleus was stained with DAPI, shown as purple color. 288 
We found that in the mice treated with NP alone, the staining of phosphorylated Smad3 was mild. It was 289 
also observed that some glomerular cells did not have nuclear localization of Smad3, indicated by 290 
separate purple spots (Fig. 7 A&B). However, in the mice receiving NP-Cy3-siOrai1 the Smad3 staining 291 
in the glomeruli was markedly increased. Also, there were fewer cells without nuclear distribution of 292 
Smad3 (Fig. 7 A&B). Summary data showed a significant increase in the total intensity of Smad3 293 
staining and a significant decrease in the number of cells without nuclear localization of Smad3 in the 294 
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mice treated with Orai1 siRNA (Fig. 7 C&D). Because the Orai1 siRNAs were specifically delivered to 295 
MCs (Fig. 6), these data suggest that knocking down Orai1 in MCs increased abundance of Smad3 and 296 
promoted nuclear translocation of Smad3. 297 
  298 
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DISCUSSION 299 
SOCE is a ubiquitous intracellular Ca
2+
 signaling pathway, serving diverse functions in many 300 
non-excitable and excitable cells (15; 28; 35; 42; 52; 54). Apart from its physiological functions, this 301 
pathway is also involved in many pathological disorders. For instance, an altered SOCE is associated 302 
with many diabetic complications (6). We have previously demonstrated that SOCE in MCs suppressed 303 
ECM protein expression (61). It is known that multiple pathways regulate synthesis and degradation of 304 
ECM proteins and thus, affect expression level of ECM proteins (11; 34). TGFβ1, a pleotropic cytokine 305 
and the most common and best characterized isoform of TGFβ, is a known pro-fibrotic factor to 306 
stimulate production of ECM proteins in MCs (48). Also, TGFβ1 signaling pathway plays a critical role 307 
in mesangial expansion and renal fibrosis in diabetic kidney disease (17; 19). Serum levels of TGFβ1 are 308 
positively correlated with the severity of diabetic nephropathy (DN), while in diabetic patients without 309 
DN those are not significantly different as compared to nondiabetic subjects (40).  Various studies have 310 
indicated that the potent fibrotic effect of TGFβ1 to be mediated via the receptor operated intracellular 311 
Smad signaling, particularly through Smad3 (14; 21; 26; 27; 46). Our results from the present study 312 
suggest that TGFβ1/Smad3 pathway is a target of SOCE for inhibition of ECM protein expression.  313 
SOCE could inhibit the TGFβ1-Smad3 signaling by acting on one or more sites of this pathway 314 
in MCs. First, it could inhibit the production or secretion of TGFβ1 by MCs. Second, SOCE could 315 
inhibit the activation of Smad3, i.e. its phosphorylation, and the third, SOCE could inhibit the nuclear 316 
translocation of Smad3. Our findings suggest that SOCE may not influence TGFβ1 production and 317 
secretion by MCs in presence of NG because activation of SOC did not change the abundance of TGFβ1 318 
in MCs and in media culturing MCs (Fig. 1).  319 
Further our study suggests that activation (phosphorylation) and nuclear translocation of Smad3 320 
are the regulatory sites for SOCE-induced inhibition of TGFβ1/Smad3 pathway. Receptor activation 321 
after TGFβ1 binding, leading to C-terminal phosphorylation of R-Smad is an important step which 322 
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destabilizes Smad interaction with Smad anchor for receptor activation (SARA), allowing dissociation 323 
of Smad from the complex and the subsequent exposure of a nuclear import region on the Smad MH2 324 
domain (63). In addition, R-Smad phosphorylation augments its affinity for Smad4 (49). The association 325 
of these two proteins translocates to the nucleus and interacts with transcriptional regulation complexes. 326 
In this study, activation of SOC significantly reduced the TGFβ1-induced phosphorylation of Smad3 in 327 
MCs (Fig. 2). However, the abundance of total Smad3 remained unaffected. Since phosphorylated 328 
Smad3 is  the active form of Smad3, a decrease in the ratio of p-Smad3 to total Smad3 indicates an 329 
inhibition of the Smad3 signaling pathway.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 330 
The inhibitory effect of SOCE on Smad3 activation (phosphorylation) was further supported by 331 
the data from experiments of manipulating Orai1 protein expression. Orai1 is the pore forming unit of 332 
store-operated Ca
2+
 channel and therefore, knocking down this channel protein would be expected to 333 
reduce SOCE. Consistent with the findings described above, knocking down Orai1 significantly 334 
enhanced TGFβ1-induced phosphorylation of Smad3 in human MCs (Fig. 3 A&B). In agreement with 335 
the results, over expressing Orai1 significantly augmented the inhibitory effect of SOCE on TGFβ1-336 
stimulated Smad3 phosphorylation (Fig. 4).   These findings are also in line with our previous reports 337 
that Orai1 knocked down increased ECM protein expression in MCs (61). Interestingly, one group 338 
recently reported that phosphorylation of Smad2/Smad3 was decreased by knocking down Orai1 in HK2 339 
cells (36). However, if this decrease was specifically due to decrease in both Smad2 and Smad3 or only 340 
Smad2 or Smad3 was not clear. This is important because Smad2 and Smad3 may have totally opposite 341 
downstream effects, Smad3 being pro-fibrotic and Smad2 as anti-fibrotic, as demonstrated by many 342 
studies (10; 38). Another possibility is that the effect of SOCE is cell type or cell context specific. Also, 343 
some studies have reported that SOCE was decreased by overexpressing Orai1 alone (20; 39; 50) 344 
However, it might not be the case in human MCs.  It might be that human MCs have spare STIM1 345 
18 
 
proteins and hence, overexpression of Orai1 may not change the stoichiometry of Orai1/STIM1 346 
complexes 347 
It is not known how SOCE inhibited phosphorylation of Smad3 by TGFβ1 from this study. 348 
Several possibilities exist.  At the level of TGFβ receptor, SOCE may inhibit the type II or type I 349 
receptor kinase which in turn, suppresses the subsequent phosphorylation of Smad3. Another   350 
mechanism could be that SOCE either activates a Ca
2+
 dependent phosphatase, such as calcineurin or a 351 
receptor specific phosphatase PP1c that dephosphorylate TGFβ receptor I (5) reducing the subsequent 352 
Smad3 phosphorylation and thus inhibiting its activation and translocation. Alternatively, SOCE could 353 
facilitate the interaction between inhibitory Smad7 and the TGFβ receptors, resulting in suppression of 354 
downstream TGFβ1/R-Smad signaling, including phosphorylation of R-Smad.  355 
Phosphorylation of Smad3 renders the receptor-operated Smad protein suitable for nuclear 356 
import, a critical step for its regulation of gene transcription. Because SOCE inhibited Smad3 357 
phosphorylation, it is not surprising that the nuclear translocation of Smad3 was depressed by activation 358 
of store-operated channel and was promoted by inhibition of the channel (Fig. 5). However, the content 359 
of nuclear Smad3 is regulated by multiple mechanisms. The change in nuclear Smad3 in response to 360 
SOCE may not only be secondary to its inhibition on phosphorylation. Effect of SOCE on other 361 
pathways regulating nuclear localization of Smad3 can’t be ruled out.  For example, SOCE may also 362 
facilitate phosphorylation in the linker region by cyclin dependent kinases (CDKs) or mitogen 363 
associated protein kinases (MAPKs) rendering Smad3 unsuitable for nuclear transport or interacts with 364 
other kinases that can affect interaction of Smad3 with import machinery like nucleoporins, nuclear 365 
retention factors (8; 33; 59). Increased export of Smad3 out of the nucleus can also be a mechanism for 366 
suppressed nuclear content of phosphorylatedSmad3 by SOCE. Nuclear localized protein phosphatase 367 
PP1MA/PP2Cα, a Smad2/3 SXS-motif specific phosphatase, dephosphorylates Smad2/3 in the nuclei 368 
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and also facilitates the interaction of dephosphorylated Smad2/3 with a nuclear export factor, RanBP3 369 
(Ran-binding protein 3) (32). 370 
TGF-β/bone morphogenetic protein-Smad signaling involves multiple types of R-Smads that 371 
may have distinct target proteins. Classically, Smad2/3 stimulates production of fibronectin and 372 
connective tissue growth factor (12; 25; 26) while Smad1 promotes collagen IV production (3). These 373 
Smad signaling pathways are present in MCs (2; 3; 9; 41; 46; 60).  We have demonstrated that SOCE 374 
inhibited production of both fibronectin and collagen IV proteins by MCs (61). In a recent study, we 375 
found that the inhibitory effect of SOCE on collagen IV protein production was through suppression of 376 
Smad1 pathway (60). In the present study, we showed that SOCE inhibited Smad3 signaling. Because 377 
Smad3 is the classic downstream pathway mediating TGF-β1-stimulated fibronectin production (12; 25; 378 
26), the negative regulation of Smad3 signaling possible is the mechanism underlying SOCE-induced 379 
downregulation of fibronectin. Therefore, SOCE in MCs may regulate different ECM proteins through 380 
distinct Smad pathways, Smad1 for collagen IV and Smad3 for fibronectin.  381 
 In summary, we defined a negative regulation of TGFβ1-Smad3 pathway by SOCE in MCs. This 382 
inhibition was through suppression of phosphorylation and nuclear translocation of Smad3, but not by 383 
decreasing abundance of TGFβ1 protein in MCs. This mechanism is illustrated in Fig. 8. Because the 384 
Smad signaling pathway plays a crucial role in matrix protein production and renal fibrosis in many 385 
kidney diseases, our findings highlight that store-operated Ca
2+
 channel may be considered as an 386 
alternative therapeutic option for treating patients with renal fibrosis. 387 
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FIGURE LEGENDS 612 
Figure 1. Effect of SOCE on TGFβ1 secretion in cultured human MCs.  613 
      ELISA, showing TGFβ1 concentration in culture media. Confluent human MCs were incubated 614 
with serum free DMEM media for 72 h. One group was without any treatment (NT) and the other 615 
groups were treated with DMSO (1:1000) or TG (1 μM) for 8 h and 15 h prior to collection of media. 616 
DMSO and TG were present in the media throughout the period of treatment. ‘n’ indicates the number 617 
of independent experiments. 618 
Figure 2. SOCE inhibited TGFβ1-induced phosphorylation of Smad3 in cultured human MCs.  619 
A: Representative Western blot, showing changes in abundance of phosphorylated Smad3 (p-Smad3) 620 
and total Smad3 (Smad3) proteins in different treatment groups. Human MCs were treated with 621 
recombinant human TGFβ1 (5 ng/ml) in presence or absence of TG (1 μM) for 15 h. NT: the cells 622 
without any treatment, HCl: 4 mM HCl with 0.1% BSA at 1:4000, the vehicle control for TGFβ1. 623 
DMSO (1:1000): the vehicle control for TG. α-tubulin was used as the loading control. B: summary 624 
data, showing changes in the ratio of p-Smad3 to Smad3 in different treatment groups. ***p<0.001 vs 625 
NT and HCl; **p<0.01 vs TGFβ1 and TGFβ1 + DMSO. ‘n’ indicates the number of independent 626 
experiments. 627 
Figure 3. Knockdown of Orai1 increased the TGFβ1-induced phosphorylation of Smad3.  628 
A: Representative Western blot, showing effect of knockdown of Orai1 on phosphorylated 629 
Smad3 (p-Smad3) and total Smad3 (Smad3) protein abundance. Human MCs were without transfection 630 
(UT) or transfected with scramble (scr) or Orai1 siRNA (siOrai1). On day 3 after transfection cells were 631 
treated with TGFβ1 (5 ng/ml) in the presence or absence of TG (1 μM) for 15 h.  α-tubulin was used as 632 
the loading control. L: protein ladder. B:  Summary data from experiments presented in A. The 633 
abundance of p-Smad3 is expressed as the ratio of p-Smad3 to Smad3.  **p<0.01 ***p<0.001 vs UT; 634 
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*p<0.05 vs TGFβ1, TGFβ1+Scr and TGFβ1+siOrai1+TG; #p<0.05 vs TGFβ1+siOrai1+TG; ##p<0.01 635 
vs TGFβ1+siOrai1. ‘n’ indicates the number of independent experiments. 636 
Figure 4. Overexpression of Orai1 decreased the TGFβ1-induced phosphorylation of Smad3. 637 
A: Representative Western blot, showing phosphorylated Smad3 (p-Smad3) and total Smad3 638 
(Smad3) protein abundance in human MCs in different groups. Human MCs were without transfection 639 
or were transfected with YFP plasmid (YFP) or mCherry-FLAG-Red Orai1 expression plasmid (Orai1). 640 
On day 2 after transfection, cells were treated with TGFβ1 (5 ng/ml) in the presence or absence of TG (1 641 
μM) for 15 h. UT: cells without transfection and treatment, DMSO (1:1000): vehicle control for TG. α-642 
tubulin was used as the loading control.  B: Summary data showing changes in p-Smad3/ Smad3 ratio in 643 
different groups. ***p<0.01, vs UT; *p<0.05, vs TGFβ1, TGFβ1+DMSO, TGFβ1+Orai1+TG. ‘n’ 644 
indicates the number of independent experiments. C: Western blot, showing endogenous Orai1 and 645 
expressed Orai1 protein contents in human MCs transfected with YFP and Orai1. The expressed Orai1 646 
protein was probed with primary antibody against Orai1 (the top panel) and flag (the middle panel). D: 647 
Effect of overexpression of Orai1 on SOCE in human MCs. Fura-2 fluorescence ratiometry was used to 648 
assess the intracellular Ca
2+
 concentration ([Ca
2+
]i) in MCs without transfection (untrans),  transfected 649 
with YFP plasmid or mCherry-FLAG-Red Orai1 expression plasmid (Orai1). SOCE was evaluated 650 
using a Ca
2+
 re-addition protocol. TG (1 µM) was used to activate store-operated Ca
2+
 channels. ** 651 
denotes P< 0.01, compared to both Untrans and YFP groups. “n” indicates the number of cells analyzed 652 
in each group. 653 
Figure 5. SOCE decreased TGFβ1-stimulated nuclear translocation of Smad3 in human MCs. 654 
A: Representative Western blot, showing phosphorylated Smad3 (p-Smad3) protein abundance 655 
in nuclear extracts of human MCs. Human MCs were either without treatment (NT) or treated with 656 
recombinant human TGFβ1 (5 ng/ml) in the presence or absence of TG (1 μM) or a selective blocker of 657 
SOCE, La
3+
 (5 μM) for 15 h. HCl: vehicle control for TGFβ1, DMSO: vehicle control for TG. TBP was 658 
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used as the loading control for the nuclear proteins. L: protein ladder. B: Summary data from 659 
experiments presented in A. ***p<0.001, vs. NT and HCl; *p<0.05 vs. TGFβ1, TGFβ1+DMSO, 660 
TGFβ1+TG+La3+. ‘n’ indicates the number of independent experiments. C. Representative images of 661 
immunofluorescence staining, showing Smad3 expression in human MCs treated with TGFβ1 (5 ng/ml) 662 
in the presence or absence of TG (1 μM) or GSK-7975A (10 μM) for 15 h. NT: cells without treatment, 663 
DMSO: vehicle control for TG. Smad3 is shown as red. Nuclei were stained with DAPI and shown as 664 
blue. Purple indicates co-localization of Smad3 with nuclei. Arrows indicate distribution of Smad3 in 665 
the cytosol. D: Summary data from 3 independent experiments, showing percentages of cells in which 666 
Smad3 was entirely localized in the nucleus in all cells counted. In each experiment, 3-4 fields were 667 
randomly selected and captured for analysis. ** denotes P<0.01, compared with NT group; †denotes 668 
P<0.01, compared with groups of TGFβ1, TGFβ1 + DMSO, and TGFβ1 + TG + GSK. The numbers 669 
under each bar (n) represent the total numbers of cells analyzed from 5 image fields per experiment of 3 670 
independent experiments. 671 
Figure 6. Distribution of NP-Cy3-siOrai1 in MCs in mouse kidney.   672 
A: Representative images from 3 mice, showing localization of NP-Cy3-siOrai1 (red) in 673 
glomeruli (indicated by arrows), but not in tubules. Original magnification: 200X. B: Localization of 674 
NP-Cy3-siOrai1 in MCs (upper panel) but not in podocytes (lower panel), representative from 3 mice. 675 
MCs and podocytes were stained with Integrin-α8 (green) and synaptopodin (green), respectively. NP-676 
Cy3-siOrai1 was shown as red signals. Original magnification: 200X. 677 
Figure 7. Knockdown of Orai1 in MCs increased phosphorylation and nuclear translocation of 678 
Smad3 in mice.  679 
A: Representative images for immuno-histochemical staining of phophosylated Smad3 (p-Smad3) on 680 
paraffin embedded kidney sections from NP-alone and NP-Cy3-siOrai1 injected mice. p-Smad3 staining 681 
is indicated as brown while nuclei are shown blue. Glomeruli are indicated by arrows. Original 682 
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magnification 200X. B: Magnified images of the region indicated by dashed boxes in A. C: Integrated 683 
density (ID) of phosphor-Smad3 staining averaged from 3 NP-Con mice and 3 NP-Cy3-siOrai1-treated 684 
mice. ** denotes P<0.01, compared to NP-Control. The numbers in parentheses under each bar represent 685 
the number of glomeruli counted from 5 sections per kidney. D: The percentage of cells without nuclear 686 
Smad3 in all cells counted in glomeruli, averaged from 3 NP-Con mice and 3 NP-Cy3-siOrai1-treated 687 
mice. ** denotes P<0.01, compared to NP-Control. The numbers in parentheses under each bar represent 688 
the number of glomeruli counted from 5 sections per kidney. 689 
Figure 8.  The diagram illustrating the negative regulation of TGFβ1-Smad3 signaling by SOCE 690 
in MCs.  691 
p-Smad3: phosphorylated Smad3. Red line indicates inhibition and blue arrows indicate promotion of 692 
the pathway. 693 
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Table1. siRNAs used for transient transfection. 
 
siRNA Sequence Gene Accession 
number/ 
catalog number
ON_TARGETplus 
Non-targeting 
control siRNA#1
Target sequence
UGGUUUACAUGUCGACUAA D-001810-01-20
Human Orai1 
siRNA (sense 
strand)
5’-UGGAACUGUCGGUCAGUCUUAUGGC-3’ NM_032790
Cy3 Mouse Orai1 
siRNA (sense 
strand)
5’-/5Cy3/ GGGUUGCUCAUCGUCUUUAGUGC-3’ NM_175423
 
